Titre :
  • CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01)
Auteur : Pestalozzi, Bernhard Cornelius B.C. ; Holmes, Eileen ; Azambuja, Evandro ; Metzger-Filho, Otto ; Hogge, Laurence L. ; Scullion, Matt M. ; Lang, Istvan ; Wardley, Andrew ; Lichinitser, Mikhail ; Sanchez, Roberto I Lopez R.I.L. ; Müller, Volkmar ; Dodwell, David ; Gelber, Richard ; Piccart-Gebhart, Martine ; Cameron, David A
Informations sur la publication : Lancet oncology, 14, 3, (page 244-248)
Statut de publication : Publié, 2013-03
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Agents -- administration & dosage -- adverse effects
Breast Neoplasms -- drug therapy -- genetics -- mortality -- pathology
Central Nervous System Neoplasms -- chemically induced -- secondary
Chemotherapy, Adjuvant -- adverse effects
Clinical Trials as Topic
Disease-Free Survival
Female
Humans
Middle Aged
Neoplasm Staging
Receptor, ErbB-2 -- genetics
Recurrence
Retrospective Studies
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:1470-2045 
info:doi/10.1016/S1470-2045(13)70017-2
info:pii/S1470204513700172
info:pmid/23414588